BCG

First Women’s Bank announces new Mission Partners Airbnb, BCG, Principal®, Salesforce and Envestnet have joined the Bank to help close the gender gap in access to capital

Retrieved on: 
Thursday, December 1, 2022

First Womens Bank (FWB) announced that Airbnb, BCG, Principal Financial Group, Salesforce and Envestnet are the Banks newest Mission Partners.

Key Points: 
  • First Womens Bank (FWB) announced that Airbnb, BCG, Principal Financial Group, Salesforce and Envestnet are the Banks newest Mission Partners.
  • Closing the gender lending gap is a critical step toward achieving gender equality, and First Womens Bank is the bank to do it, said Marianne Markowitz, president and CEO, First Womens Bank.
  • First Womens Bank will help bridge that gap and promote more inclusive economic growth with the support of our Mission Partners and the trailblazing women that have joined FWB as Strategic Advisors.
  • The support of FWBs Mission Partners helps to expand economic opportunity for all small businesses with a strategic focus on the womens economy.

BCG Creates BCG X as New Hybrid of Consulting and Tech Build & Design Capabilities

Retrieved on: 
Thursday, December 1, 2022

To tip the scales, we are doubling down on BCG X, our nearly 3,000-person tech build and design unit.

Key Points: 
  • To tip the scales, we are doubling down on BCG X, our nearly 3,000-person tech build and design unit.
  • BCG X, as an integral part of BCG, will bring tech build and design capabilities together to solve these problems."
  • To help clients respond to these challenges and address these pain points, BCG has launched BCG X, a hybrid tech build & design unit that brings together nearly 3,000 technologists, builders, and designers.
  • This cannot be achieved by consultants or tech vendors alonetogether, BCG and BCG X bring to life ambitious tech and business builds at scale.

Emeritus and Stanford Graduate School of Business Enter Multi-Year Collaboration to Expand Global Access to World-Class Business Education

Retrieved on: 
Thursday, December 1, 2022

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Emeritus, the global leader in world-class professional education, today announced a collaboration with Stanford Executive Education at Stanford Graduate School of Business (GSB). Together they will launch a suite of small private online courses to equip professionals, executives, and organizations with skills for navigating the fast-changing global economy. The collaboration will allow Stanford Graduate School of Business to reach new global audiences and expand its mission to develop innovative and principled leaders, with Emeritus bringing global reach and depth of experience in online education.

Key Points: 
  • NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Emeritus , the global leader in world-class professional education, today announced a collaboration with Stanford Executive Education at Stanford Graduate School of Business (GSB).
  • The collaboration will allow Stanford Graduate School of Business to reach new global audiences and expand its mission to develop innovative and principled leaders, with Emeritus bringing global reach and depth of experience in online education.
  • This collaboration with Stanford GSB will further Emeritus' mission of making high-quality education accessible and affordable to learners around the world.
  • About Stanford Graduate School of Business Executive Education:
    Stanford Graduate School of Business offers more than 100 short courses and certificate programs annually through its Stanford Executive Education program.

Adyen Empowers Accounting Platform Moneybird to Offer Financial Services

Retrieved on: 
Tuesday, November 29, 2022

AMSTERDAM, Nov. 29, 2022 /PRNewswire/ -- Adyen (AMS: ADYEN), the global financial technology platform of choice for leading businesses, announces that software as a service (SaaS) platform, Moneybird, is the latest customer utilizing its newly launched suite of embedded financial products. Designed to simplify accounting processes for entrepreneurs, Moneybird facilitates bookkeeping needs ranging from vendor onboarding to invoicing and VAT reconciliation. To further meet their user's business needs, Moneybird has integrated Adyen's card issuing and business accounts - taking their offering from balance sheet oversight to fully embedded financial services. Moneybird users can now enjoy the synergies between accounting and banking, which go hand-in-hand to provide complete cash flow management.

Key Points: 
  • Adyen is rounding out the SaaS platform's offering with card issuing, accounts, and capital
    AMSTERDAM, Nov. 29, 2022 /PRNewswire/ -- Adyen (AMS: ADYEN), the global financial technology platform of choice for leading businesses, announces that software as a service (SaaS) platform, Moneybird, is the latest customer utilizing its newly launched suite of embedded financial products.
  • Designed to simplify accounting processes for entrepreneurs, Moneybird facilitates bookkeeping needs ranging from vendor onboarding to invoicing and VAT reconciliation.
  • "In addition to embedding payments, the more tailored financial services a platform can provide, the more attractive they become to current and potential users.
  • Adyen (AMS: ADYEN) is the financial technology platform of choice for leading companies.

2022 Bladder Cancer Update Bulletin: Key Opinion Leader (KOL) Views on Recent Developments - ResearchAndMarkets.com

Retrieved on: 
Monday, November 28, 2022

The "Bladder Cancer: Update Bulletin #2" newsletter has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bladder Cancer: Update Bulletin #2" newsletter has been added to ResearchAndMarkets.com's offering.
  • This edition presents leading key opinion leader (KOL) views on recent developments in the Bladder Cancer market.
  • How do the KOLs perceive the Phase II combination results for BMS' Opdivo with the IDO inhibitor BMS-986205 in patients with advanced bladder cancer?
  • What are experts' thoughts on PD-L1 expression and its future use as a biomarker in patients with bladder cancer?

EQS-News: LINDIS Biotech Presented Encouraging Data from Non-Muscle-Invasive Bladder Cancer Patients Treated with Trifunctional Antibody CATUMAXOMAB at EMUC22

Retrieved on: 
Sunday, November 27, 2022

Consistent with previous findings, CATUMAXOMAB was well tolerated, and there was no dose limiting toxicity.

Key Points: 
  • Consistent with previous findings, CATUMAXOMAB was well tolerated, and there was no dose limiting toxicity.
  • Treatment emergent adverse events (AEs) were only of grade 1-2, no serious adverse events (SAEs) were observed.
  • Our previously released compassionate use data, as well as the positive results and follow-up data from the dose escalation are strongly encouraging.
  • The antibody recognizes and binds to all EpCAM-positive tumor cells, including critical cancer stem cells and all CD3-positive T cells.

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation

Retrieved on: 
Friday, November 25, 2022

SHENZHEN & HONG KONG, China, Nov. 24, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide.

Key Points: 
  • XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types.
  • Currently, the design and preclinical development process for tumour vaccines is complex and lengthy, hindering the efficiency and success rate of tumour vaccine research and development.
  • We believe the AI cancer vaccine platform jointly developed by CK Life Sciences and XtalPi will inspire the global scientific community to progress vaccine research and development and fast-track key development milestones for cancer vaccines.
  • Dr. Melvin Toh, Vice President and Chief Scientific Officer of CK Life Sciences, comments: "The R&D of tumour vaccines is one of the key development directions of CK Life Sciences.

Pediatric Vaccines Global Markets Report 2022: Impacts of COVID-19, Market Revenue Data for 2020 and 2021, Estimates for 2022, and CAGR Projections through 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022

This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities.

Key Points: 
  • This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities.
  • The report also covers market projections through 2027 and estimates market shares for key players, as well as pediatric vaccines by type and by application.
  • The report also discusses the impact of the COVID-19 pandemic on this market.
  • Vaccines are one of the most significant advances in global health and are the most cost-effective strategy to reduce child mortality.

Gulf Coast Sequestration and Climeworks Sign MOU to Develop First Direct Air Capture and Storage Hub on the Gulf Coast in Louisiana

Retrieved on: 
Monday, November 21, 2022

Gulf Coast Sequestration (GCS), a Louisiana-based company building the largest carbon sequestration hub in North America, and leading direct air capture (DAC) company Climeworks today announced the signing of a Memorandum of Understanding (MOU).

Key Points: 
  • Gulf Coast Sequestration (GCS), a Louisiana-based company building the largest carbon sequestration hub in North America, and leading direct air capture (DAC) company Climeworks today announced the signing of a Memorandum of Understanding (MOU).
  • GCS matches Climeworks pioneering DAC technology with comprehensively studied geologic pore space ideally suited for a world-class carbon storage project.
  • Congratulations to Climeworks and Gulf Coast Sequestration on announcing this innovative collaboration, said Louisiana Governor John Bel Edwards.
  • Direct air capture (DAC) is a key technology for removing unavoidable and historic CO2 from the air, said Climeworks co-CEO Jan Wurzbacher.

ImmunityBio to Participate in 34th Annual Piper Sandler Healthcare Conference

Retrieved on: 
Thursday, November 17, 2022

ImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases.

Key Points: 
  • ImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases.
  • These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
  • ImmunityBio cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof.
  • ImmunityBio does not undertake any duty to update any forward-looking statement or other information in this press release, except to the extent required by law.